Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) February 22-25, 2016, Boston MA Back

Genotypic and Phenotypic Characterization of Clinical HCV NS5A Drug Resistance       Reported by Jules Levin CROI 2016 Feb 22-24 Boston   WEBCAST of Themed Discussion - HCV RAVs: http://www.croiwebcasts.org/console/player/29510?mediaType=audio& "NS5A RAVs were identified in 286/776 (36.9%) GT1a viruses and 85/197 (43.1%) GT1b viruses (Figure 1)......Of the 286 GT1a samples with RAVs, 165 (57.7%) harbored a single RAV and 121 (42.3%) had more than one RAV (Figure 2B)."